Author

Anna María Geretti

University of Rome Tor VergataORCID 0000-0002-3670-6588Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adam AbdullahiiD· 1 shared Ana García-Díaz· 1 shared Apostolos I. BeloukasiD· 1 shared Charles KouanfackiD· 1 shared Judith Ndongo Embola TorimiroiD· 1 shared Olga Mafotsing Fopoussi· 1 shared Victoire Fokom Defo· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adam AbdullahiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologyJournal of Antimicrobial ChemotherapyPeer-reviewedDec 28, 2023

A detailed characterisation of drug resistance during darunavir/ritonavir (DRV/r) monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

Adam Abdullahi, Ana García-Díaz, Olga Mafotsing Fopoussi…·Anna María Geretti

This study characterizes drug resistance during DRV/r monotherapy, finding no DRV resistance mutations but identifying alternative resistance pathways through gag substitutions.

7 citations

humanbulk RNA-seq

𝕏 PostBluesky